Registered Uganda · NDA

DIPHTHERIA TOXOID + TETANUS TOXOID + INACTIVATED WHOLE CELL BORDETELLA PERTUSSIS + HEPATITIS B SURFACE ANTIGEN (RDNA) + HIB POLYSACCHARIDE COVALENTLY BOUND TO TT (PRP-TT)

NDA/MAL/HDP/11820 PARENTERAL ORDINARY VIALS (? 30 IU (? 20 LF TO ?30 LF) + ? 60 IU (? 5 LF TO ? 25 LF) + > 4 IU + >10 µG + >10 µG)0.5 ML

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.

NDA/MAL/HDP/11820

Registration date

18/12/2024

Expiry date

Status

Registered

Active ingredient

Dosage form

PARENTERAL ORDINARY VIALS

Strength

(? 30 IU (? 20 LF TO ?30 LF) + ? 60 IU (? 5 LF TO ? 25 LF) + > 4 IU + >10 µG + >10 µG)0.5 ML

Pack size

I. 1*1*0.5ML VIAL

Therapeutic class

Manufacturer / MAH

Human Biologicals Institute Rakshapuram, Gachibowli Post, Hyderabad

Applicant / LTR

HUMAN BIOLOGICALS INSTITUTE (A DIVISION OF INDIAN IMMUNOLOGICALS LIMITED)

Country of origin

INDIA

Manufacturer location

Rakshapuram, opposite to Stadium, Indian Immunologicals Colony, Gachibowli, Hyderabad, Telangana 500032, India

Source: National Drug Authority · fetched 2026-04-21 17:37:05 · updated 2026-09-12 04:00:20

Disclaimer: This information is sourced from National Drug Authority (Uganda). Always consult a qualified healthcare professional before using any medication.